Wuhan Hvsen Biotechnology Co Ltd Net Asset Quality Index
Wuhan Hvsen Biotechnology Co Ltd net asset quality index. Wuhan Hvsen Biotechnology Co Ltd (300871) has a Net Asset Quality Index of 68.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.41 Billion minus total liabilities of CN¥1.08 Billion yields net assets of CN¥2.33 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Wuhan Hvsen Biotechnology Co Ltd (300871) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Wuhan Hvsen Biotechnology Co Ltd (2016–2025)
Net asset quality index of Wuhan Hvsen Biotechnology Co Ltd from 2016 to 2025. This chart shows how Wuhan Hvsen Biotechnology Co Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 68.2%, representing net assets of CN¥2.33 Billion against total assets of CN¥3.41 Billion CNY. Check 300871 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Wuhan Hvsen Biotechnology Co Ltd Net Asset Quality Index by Year (2016–2025)
Wuhan Hvsen Biotechnology Co Ltd net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Wuhan Hvsen Biotechnology Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Wuhan Hvsen Biotechnology Co Ltd (300871) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.7% | CN¥2.19 Billion | CN¥3.01 Billion | CN¥822.17 Million | ▲ +24.1 pp |
| 2024 | 48.6% | CN¥1.47 Billion | CN¥3.01 Billion | CN¥1.55 Billion | ▼ -2.1 pp |
| 2023 | 50.7% | CN¥1.51 Billion | CN¥2.98 Billion | CN¥1.47 Billion | ▼ -0.8 pp |
| 2022 | 51.6% | CN¥1.54 Billion | CN¥2.99 Billion | CN¥1.45 Billion | ▼ -7.5 pp |
| 2021 | 59.0% | CN¥1.62 Billion | CN¥2.74 Billion | CN¥1.12 Billion | ▼ -19.7 pp |
| 2020 | 78.7% | CN¥1.38 Billion | CN¥1.75 Billion | CN¥373.08 Million | ▲ +20.5 pp |
| 2019 | 58.2% | CN¥378.28 Million | CN¥650.08 Million | CN¥271.80 Million | ▼ -11.4 pp |
| 2018 | 69.5% | CN¥324.52 Million | CN¥466.60 Million | CN¥142.08 Million | ▲ +4.7 pp |
| 2017 | 64.8% | CN¥223.11 Million | CN¥344.18 Million | CN¥121.06 Million | ▲ +4.4 pp |
| 2016 | 60.5% | CN¥154.70 Million | CN¥255.86 Million | CN¥101.16 Million | — |